cyclophosphamide and busulfan followed by donor stem cell transplant
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for cyclophosphamide and busulfan followed by donor stem cell transplant, covering 2018-01-02 to 2018-01-02. Get the full timeline:
Most recent: Clinical Trial Update: Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome [NA]